As seen with increased circulating insulin in T2DM, excess leptin in the setting of obesity also promotes leptin resistance (35), but whether altered leptin signaling or other traits of MetS foster ADRD-related pathologies is not well understood. The gene discussed is INS; the disease is metabolic syndrome.